Analyst Raises DexCom 12-Month Price Target to $98.08
DexCom's 12-month price target was raised to $98.08, implying 23% upside.
Story updates
01:33:20 PM UTC
SquawkNews
On October 30, 2026, multiple financial institutions updated their outlook on DexCom, Inc. Raymond James adjusted its price target for the company's stock to $97 from $94. Additionally, Barclays revised its price target for DexCom to $120 from $115. These adjustments follow the company's recent third-quarter 2026 earnings report, which included an increase in its full-year 2026 revenue guidance.